Utility of Blood Culture in Patients with Community-Acquired Pneumonia: A Propensity Score-Matched Analysis Based on a Japanese National Health Insurance Database

被引:0
|
作者
Muro, Takahiro [1 ]
Ando, Fumihiko [1 ]
Suehiro, Marie [1 ]
Nakagawa, Hiroo [2 ]
Okuda, Chieko [3 ]
Matsumoto, Takehiro [4 ]
Izumikawa, Koichi [5 ]
Honda, Masayuki [6 ]
Sasaki, Hitoshi [7 ]
机构
[1] Nagasaki Int Univ, Fac Pharmaceut Sci, Dept Pharm, Div Med Informat, Nagasaki 8593298, Japan
[2] Nagasaki Univ Hosp, Dept Clin Pharm, Nagasaki 8528501, Japan
[3] Yokohama Univ Pharm, Yokohama 2450066, Japan
[4] Nagasaki Univ Hosp, Dept Med Informat, Nagasaki 8528501, Japan
[5] Nagasaki Univ Hosp, Infect Control & Educ Ctr, Nagasaki 8528501, Japan
[6] Nagasaki Univ, Nagasaki 8528521, Japan
[7] Nagasaki Univ, Inst Trop Med, Nagasaki 8528523, Japan
关键词
community-acquired pneumonia; antibiotics; blood culture; inpatient; INFLAMMATORY RESPONSE SYNDROME; INFECTIOUS-DISEASES-SOCIETY; THORACIC-SOCIETY; GUIDELINES; SEPSIS; IMPACT;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Community-acquired pneumonia (CAP) is an acute pulmonary parenchymal infection acquired outside the hospital. The utility of blood cultures in inpatients with CAP to reduce mortality and length of hospital stay is controversial. This study aimed to determine the utility of blood cultures on the first day of hospital-ization for CAP inpatients and its influence on mortality, length of hospital stay, and antibiotics use. We con-ducted a fact-finding survey on the implementation of blood culture in inpatients with CAP in Japan. A pro-pensity score (PS)-matched analysis based on the National Database of Health Insurance Claims and Specific Health Check-ups of Japan database was conducted. Overall, 163173 patients were included in the analysis, and PS matching extracted 68104 pairs. The results of the comparison between the PS-matched blood culture group and PS-matched control group were as follows: mortality and length of hospital stay were significantly lower in the PS-matched blood culture group than in the control group. The adjusted odds ratio (OR) (95% confidence interval (CI)) for in-hospital mortality with blood culture test was 0.73 (0.68-0.79). Moreover, for days of antibiotic usage, number of antibiotics used were significantly higher in the PS-matched blood culture group than that in the control group. Our findings indicated that performing a blood culture on the first day of hospitalization for inpatients with CAP was associated with reduced mortality. To our knowledge, this is the largest epidemiological study to assess the utility of blood culture in Japanese inpatients with CAP. This testing method shows potential for application in clinical practice.
引用
收藏
页码:237 / 244
页数:8
相关论文
共 50 条
  • [1] Antibiotics for hospitalized children with community-acquired pneumonia in Japan: Analysis based on Japanese national database
    Yahaba, Misuzu
    Yamagishi, Kazutaka
    Yamazaki, Shingo
    Takayanagi, Shin
    Kawasaki, Yohei
    Taniguchi, Toshibumi
    Ishiwada, Naruhiko
    Igari, Hidetoshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2021, 27 (03) : 461 - 465
  • [2] Comparing Outcomes of Community-Acquired Pneumonia Patients Discharged from General Medicine and Respiratory Units in Australia: A Propensity Score-Matched Analysis
    Sharma, Yogesh
    Mangoni, Arduino A.
    Shahi, Rashmi
    Horwood, Chris
    Thompson, Campbell
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (10)
  • [3] Utility of Blood Culture Among Children Hospitalized With Community-Acquired Pneumonia
    Neuman, Mark I.
    Hall, Matthew
    Lipsett, Susan C.
    Hersh, Adam L.
    Williams, Derek J.
    Gerber, Jeffrey S.
    Brogan, Thomas V.
    Blaschke, Anne J.
    Grijalva, Carlos G.
    Parikh, Kavita
    Ambroggio, Lilliam
    Shah, Samir S.
    PEDIATRICS, 2017, 140 (03)
  • [4] Azithromycin combination therapy for community-acquired pneumonia: propensity score analysis
    Ito, Akihiro
    Ishida, Tadashi
    Tachibana, Hiromasa
    Tokumasu, Hironobu
    Yamazaki, Akio
    Washio, Yasuyoshi
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
    Cilloniz, Catia
    Mendez, Raul
    Peroni, Hector
    Garcia-Vidal, Carolina
    Rico, Veronica
    Gabarrus, Albert
    Menendez, Rosario
    Torres, Antoni
    Soriano, Alex
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (02) : 271 - 279
  • [6] Prognostic significance of malnutrition for long-term mortality in community-acquired pneumonia: a propensity score matched analysis
    Yeo, Hye Ju
    Byun, Ki Sup
    Han, Junhee
    Kim, June Hyun
    Le, Seung Eun
    Yoon, Seong Hoon
    Eon, Doosoo
    Kim, Yun Seong
    Cho, Woo Hyun
    KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04) : 841 - 849
  • [7] Treatment of Community-Acquired Pneumonia in Adults: Analysis of the National Dispensing Database
    Matuz, Maria
    Bognar, Julia
    Hajdu, Edit
    Doro, Peter
    Bor, Andrea
    Viola, Reka
    Soos, Gyongyver
    Benko, Ria
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (05) : 330 - 334
  • [8] Aspirin reduces the mortality risk of patients with community-acquired pneumonia: a retrospective propensity-matched analysis of the MIMIC-IV database
    Wang, Guangdong
    Sun, Jiaolin
    Zhang, Yaxin
    Wang, Na
    Liu, Tingting
    Ji, Wenwen
    Lv, Lin
    Yu, Xiaohui
    Cheng, Xue
    Li, Mengchong
    Hu, Tinghua
    Shi, Zhihong
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [9] The natural history of community-acquired pneumonia in COPD patients: A population database analysis
    Muellerova, Hana
    Chigbo, Chuba
    Hagan, Gerry W.
    Woodhead, Mark A.
    Miravitlles, Marc
    Davis, Kourtney J.
    Wedzicha, Jadwiga A.
    RESPIRATORY MEDICINE, 2012, 106 (08) : 1124 - 1133
  • [10] Effect of positive microbiological testing on antibiotic de-escalation and outcomes in community-acquired pneumonia: a propensity score analysis
    Abelenda-Alonso, Gabriela
    Rombauts, Alexander
    Gudiol, Carlota
    Garcia-Lerma, Esther
    Pallares, Natalia
    Ardanuy, Carmen
    Calatayud, Laura
    Niubo, Jordi
    Tebe, Cristian
    Carratala, Jordi
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (12) : 1602 - 1608